NO20053754L - Improved radiometal complex compositions. - Google Patents

Improved radiometal complex compositions.

Info

Publication number
NO20053754L
NO20053754L NO20053754A NO20053754A NO20053754L NO 20053754 L NO20053754 L NO 20053754L NO 20053754 A NO20053754 A NO 20053754A NO 20053754 A NO20053754 A NO 20053754A NO 20053754 L NO20053754 L NO 20053754L
Authority
NO
Norway
Prior art keywords
improved
complex compositions
radiometal complex
radiometal
compositions
Prior art date
Application number
NO20053754A
Other languages
English (en)
Norwegian (no)
Other versions
NO20053754D0 (no
Inventor
Ingrid Henriksen
David Mcgill
Original Assignee
Ge Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare Ltd filed Critical Ge Healthcare Ltd
Publication of NO20053754D0 publication Critical patent/NO20053754D0/no
Publication of NO20053754L publication Critical patent/NO20053754L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20053754A 2003-02-07 2005-08-05 Improved radiometal complex compositions. NO20053754L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03002809A EP1444990A1 (en) 2003-02-07 2003-02-07 Improved Radiometal Complex Compositions
PCT/GB2004/000443 WO2004069285A1 (en) 2003-02-07 2004-02-09 Improved radiometal complex compositions

Publications (2)

Publication Number Publication Date
NO20053754D0 NO20053754D0 (no) 2005-08-05
NO20053754L true NO20053754L (no) 2005-10-05

Family

ID=32605351

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20053754A NO20053754L (no) 2003-02-07 2005-08-05 Improved radiometal complex compositions.

Country Status (16)

Country Link
US (1) US20070020177A1 (enExample)
EP (2) EP1444990A1 (enExample)
JP (2) JP2006528205A (enExample)
KR (1) KR20050103221A (enExample)
CN (1) CN100548387C (enExample)
AT (1) ATE487498T1 (enExample)
AU (1) AU2004210191B2 (enExample)
BR (1) BRPI0407056A (enExample)
CA (1) CA2514307A1 (enExample)
DE (1) DE602004029983D1 (enExample)
ES (1) ES2355100T3 (enExample)
MX (1) MXPA05008356A (enExample)
NO (1) NO20053754L (enExample)
RU (1) RU2005123799A (enExample)
WO (1) WO2004069285A1 (enExample)
ZA (1) ZA200506728B (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1444990A1 (en) * 2003-02-07 2004-08-11 Amersham plc Improved Radiometal Complex Compositions
US8741261B2 (en) 2003-12-18 2014-06-03 Ge Healthcare Limited Methods for carbon isotope labeling synthesis by transition metal-promoted carbonylation via isocyanate using azides and carbon-isotope monoxide
WO2006134424A2 (en) * 2004-12-03 2006-12-21 Ge Healthcare Limited Method for the use of [11c] carbon monoxide in labeling synthesis of 11c-labelled acids by photo-induced free radical carbonylation
GB0428020D0 (en) 2004-12-22 2005-01-26 Amersham Health As Stabilisation of radiopharmaceutical precursors
WO2006082497A1 (en) * 2005-02-01 2006-08-10 Ge Healthcare Limited Method for the use of [11c] carbon monoxide in labeling synthesis of 11c-labelled compounds by thermally induced free radical carbonylation
US20060217537A1 (en) * 2005-03-22 2006-09-28 Bengt Langstrom Methods for carbon isotope labeling synthesis by transition metal-promoted carbonylation via ketene using diazo compounds and carbon-isotope monoxide
CA2610252A1 (en) * 2005-06-14 2006-12-21 Nihon Medi-Physics Co., Ltd. Radioactive diagnostic imaging agent
WO2007026216A1 (en) * 2005-08-31 2007-03-08 Ge Healthcare Limited Method for the use of [11c] carbon monoxide in labeling synthesis of 11c-labelled ketones by photo-induced free radical carbonylation
EP2080526A4 (en) * 2006-11-09 2012-11-07 Nihon Mediphysics Co Ltd RADIOACTIVE DIAGNOSTIC IMAGING DAY
RU2366434C1 (ru) * 2007-12-07 2009-09-10 Институт неорганической химии им. А.В. Николаева Сибирского отделения Российской Академии наук Гексаядерные кластерные комплексы рения на основе радиоактивных изотопов, обладающие противоопухолевыми свойствами
GB0922023D0 (en) * 2009-12-17 2010-02-03 Ge Healthcare Ltd Preparation of n-monofluoroalkyl compounds
US9951324B2 (en) 2010-02-25 2018-04-24 Purdue Research Foundation PSMA binding ligand-linker conjugates and methods for using
JP6244203B2 (ja) * 2010-07-27 2017-12-06 ジーイー・ヘルスケア・リミテッド 放射性医薬組成物
US9636413B2 (en) * 2012-11-15 2017-05-02 Endocyte, Inc. Conjugates for treating diseases caused by PSMA expressing cells
JP2016510342A (ja) * 2013-02-15 2016-04-07 トーマス・ジェファーソン・ユニバーシティＴｈｏｍａｓ Ｊｅｆｆｅｒｓｏｎ Ｕｎｉｖｅｒｓｉｔｙ 腫瘍画像化のためのキット
AU2014336638C1 (en) 2013-10-18 2020-09-17 Novartis Ag Labeled inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer
EP4541378A3 (en) 2013-11-14 2025-07-30 Endocyte, Inc. Compounds for positron emission tomography
US20150375901A1 (en) * 2014-06-30 2015-12-31 Karen J. Orlich Reusable, eco-friendly container for storing and dispensing food and beverage
US10188759B2 (en) 2015-01-07 2019-01-29 Endocyte, Inc. Conjugates for imaging
RU2624237C1 (ru) * 2016-10-26 2017-07-03 Федеральное государственное бюджетное учреждение "Государственный научный центр Российской Федерации - Федеральный медицинский биофизический центр имени А.И. Бурназяна" Радиофармацевтическая композиция для радиосиновэктомии и способ ее получения
USD905136S1 (en) 2018-03-05 2020-12-15 Bliss Industries, Llc Hammermill hammer
US10610870B2 (en) 2017-08-21 2020-04-07 Bliss Industries, Llc Hot and cold forming hammer and method of assembly
US10207274B1 (en) 2017-08-21 2019-02-19 Roger Young Non-forged hammermill hammer
US10486160B2 (en) 2017-08-21 2019-11-26 Bliss Industries, Llc Method of replacing hammers and spacers
US10478824B2 (en) 2017-08-21 2019-11-19 Bliss Industries, Llc System and method for installing hammers
US12138630B2 (en) 2017-08-21 2024-11-12 Bliss Industries, Llc Hammermill hammer
USD840447S1 (en) 2017-12-06 2019-02-12 Roger Young Swing hammer
USD839934S1 (en) 2017-12-06 2019-02-05 Roger Young Swing hammer
USD861048S1 (en) 2017-12-06 2019-09-24 Roger Young Swing hammer
CN112368024A (zh) 2018-04-17 2021-02-12 恩多塞特公司 治疗癌症的方法
JP7604397B2 (ja) 2019-05-20 2024-12-23 エンドサイト・インコーポレイテッド Ｐｓｍａコンジュゲートの調製方法
WO2022156908A1 (en) * 2021-01-25 2022-07-28 Vrije Universiteit Brussel Method for preparing a lyophilized composition

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4364920A (en) * 1975-04-30 1982-12-21 Medi-Physics, Inc. Stable diagnostic reagents
US4497744A (en) * 1978-03-31 1985-02-05 Mallinckrodt, Inc. Gentisic acid salts as radiographic scanning agent stabilizers
US4233284A (en) * 1978-03-31 1980-11-11 The Procter & Gamble Company Stabilized radiographic scanning agents
EP0078642B1 (en) * 1981-10-30 1986-12-10 AMERSHAM INTERNATIONAL plc Radiopharmaceutical composition based on technetium-99m and reagent for making it
US6241963B1 (en) * 1995-10-19 2001-06-05 The Trustees Of The University Of Pennsylvania Dopamine and serotonin transporter ligands and imaging agents
US7105678B2 (en) * 1995-11-03 2006-09-12 Organix, Inc. Boat tropanes
US6171576B1 (en) 1995-11-03 2001-01-09 Organix Inc. Dopamine transporter imaging agent
US5961955A (en) * 1997-06-03 1999-10-05 Coulter Pharmaceutical, Inc. Radioprotectant for peptides labeled with radioisotope
WO2001040239A2 (en) * 1999-12-03 2001-06-07 Yale University Transition metal-cyclopentadienyl-tropane conjugates
GB0031592D0 (en) * 2000-12-28 2001-02-07 Nycomed Amersham Plc Stabilised radiopharmaceutical compositions
FR2833952B1 (fr) 2001-12-26 2004-03-26 Schering Ag Derive du tropane, produit de chelation comprenant ce derive de tropane et un metal ou un complexe de metal et radiopharmaceutique
EP1444990A1 (en) * 2003-02-07 2004-08-11 Amersham plc Improved Radiometal Complex Compositions

Also Published As

Publication number Publication date
WO2004069285A1 (en) 2004-08-19
EP1444990A1 (en) 2004-08-11
CN100548387C (zh) 2009-10-14
ES2355100T3 (es) 2011-03-22
AU2004210191A1 (en) 2004-08-19
JP2006528205A (ja) 2006-12-14
MXPA05008356A (es) 2006-03-13
BRPI0407056A (pt) 2006-01-17
ATE487498T1 (de) 2010-11-15
NO20053754D0 (no) 2005-08-05
CA2514307A1 (en) 2004-08-19
ZA200506728B (en) 2006-10-25
AU2004210191B2 (en) 2007-08-23
DE602004029983D1 (de) 2010-12-23
RU2005123799A (ru) 2006-03-27
EP1590007A1 (en) 2005-11-02
KR20050103221A (ko) 2005-10-27
US20070020177A1 (en) 2007-01-25
JP2011132258A (ja) 2011-07-07
EP1590007B1 (en) 2010-11-10
CN1767859A (zh) 2006-05-03

Similar Documents

Publication Publication Date Title
ATE487498T1 (de) Verbesserte radiometall-komplex-zusammensetzungen
DK1404377T3 (da) Forbedrede chelatorkonjugater
EA200300429A1 (ru) Способ получения порошковых композиций
ATE445418T1 (de) Radiopharmazeutische formulierungen
MXPA04003886A (es) Tiofen- y tiazolsulfonamidas como agentes antineoplasticos.
HUP0304083A2 (hu) Radiofarmakon kompozíciók, előállításuk és eljárás radiofarmakonok pufferolására
NO20071476L (no) Antidiuretiske midler.
WO2003002489A3 (en) Solid-phase electrophilic fluorination
DK1264603T3 (da) Anvendelse af L-polynukleotider til in vivo-billeddannelse
DE50206722D1 (de) Zusammensetzungen, enthaltend quaternäre Ammoniumverbindungen
GB0105224D0 (en) Improved peptide-chelate conjugates
BR0318125A (pt) Derivados de benzeno trìmeros macrociclicamente substituìdos
DK2094650T3 (da) Anvendelse af campholenderivater som duftstofingredienser i parfume og smagsstoffer
DE60322562D1 (de) Konjugate von tc komplexen und zielgerichtete einheiten und ihre verwendung in nmr-diagnostik
WO2005104696A3 (en) Non-gmo metal amino acid chelates and non-gmo metal amino acid chelate-containing compositions
BR0317852A (pt) Formulações semelhantes a óleo aspergìveis
WO2001080906A3 (en) Radiometal complexes of 2-pyrrolylthiones for imaging a therapy
DK1381397T3 (da) Stabilisering af radiofarmaceutiske præparater ved anvendelse af hydrofile thioethere
GT199900037A (es) Nuevas composiciones herbicidas.
WO2003027148A8 (en) Disulfide-reduced neogalactosyl serum albumin and use of radiolabeled derivative thereof for liver imaging
ATE459592T1 (de) Naphthalinonderivat mit gerüchen vom pulvrigen ionon-typ
ATE255586T1 (de) Chelatiermittel für radioimmunotherapie
DE60217240D1 (de) Verwendung eines Oxims als ein Parfümbestandteil
TR200301039U (tr) Setli tezgahlar için birleştirme elemanı.
HU0600248D0 (en) Compositions containing 3,7-diazabicyclo-[3,3,1]compounds as antiarhythmic agents

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application